Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Liver Transpl. 2019 Mar 29;25(5):706–711. doi: 10.1002/lt.25448

Table 1:

Patient Characteristics in ACCELERATE-AH Patients Classified as AH vs. Non-AH in UNOS Database

Classified With AH as
UNOS Diagnosis?
Characteristic Yes
(n=43)
No
(n=81)
p
Age – yr – median (IQR) 39 (34–51) 43 (37–50) 0.36
Male, n (%) 34 (79) 52 (64) 0.09
Caucasian, n (%) 34 (79) 71 (88) 0.21
Employed, n (%) 29 (67) 36 (44) 0.02
Medical Insurance
Private, n (%)
Medicare, n (%)
Medicaid, n (%)

27 (63)
6 (14)
10 (23)

58 (72)
7 (9)
16 (20)
0.54
Married / Stable Companion, n (%) 25 (58) 52 (64) 0.51
History of Co-Morbid Psychiatric Disease, n
(%)
17 (40) 30 (37) 0.78
History of Non-THC Illicit Substance Usea, n
(%)
6 (14) 9 (11) 0.61
History of Failed Rehabilitation Attempt, n (%) 13 (30) 20 (25) 0.51
History of Alcohol-Related Legal Issues, n (%) 13 (30) 20 (25) 0.51
Alcohol Consumption Immediately Prior to
Hospitalizationb – units/day – median (IQR)
12 (8–15) 8 (5–16) 0.16
Years of Heavy Drinkingc – median (IQR) 12 (6–20) 17 (8–25) 0.23
Received Corticosteroids Pre-LT for AH, n (%) 29 (67) 45 (56) 0.20
Sodium at LT – mg/dL – median (IQR) 135 (133–139) 136 (134–140) 0.09
INR at LT – median (IQR) 2.0 (1.8–2.5) 2.2 (1.8–2.7) 0.20
Bilirubin at LT – mg/dL – median (IQR) 27.2 (21.3–34.6) 23.4 (15.2–32.2) 0.11
Creatinine at LT – mg/dL – median (IQR) 2.8 (1.7–4.6) 2.1 (1.3–3.5) 0.06
Mechanical Ventilation at LT, n (%) 3 (7) 14 (17) 0.11
Renal Replacement Therapy at LT, n (%) 25 (58) 47 (58) 0.99
Na-MELD Score at LT - median (IQR) 38 (36–40) 39 (35–40) 0.74
a

1 missing value in Yes group

b

2 missing values: 1 in Yes group, 1 in No group

c

3 missing values: 1 in Yes group, 2 in No group